Related references
Note: Only part of the references are listed.Exploiting the enhanced permeability and retention effect for tumor targeting
Arun K. Iyer et al.
DRUG DISCOVERY TODAY (2006)
Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting
K Greish et al.
CLINICAL PHARMACOKINETICS (2003)
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases
J Wu et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Tumor-targeted chemotherapy with SMANCS in Lipiodol for renal cell carcinoma: Longer survival with larger size tumors
K Tsuchiya et al.
UROLOGY (2000)
Focal therapeutic efficacy of transcatheter arterial infusion of styrene maleic acid neocarzinostatin for hepatocellular carcinoma
S Abe et al.
JOURNAL OF GASTROENTEROLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
